5966 related articles for article (PubMed ID: 2470106)
1. Characterization of a human-mouse chimeric antibody reactive with a human melanoma associated antigen.
Marchitto KS; Kindsvogel WR; Beaumier PL; Fine SK; Gilbert T; Levin SD; Woodhouse CS; Morgan AC
Prog Clin Biol Res; 1989; 288():101-5. PubMed ID: 2470106
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific genetically engineered murine/human chimeric monoclonal antibody.
Brown BA; Davis GL; Saltzgaber-Muller J; Simon P; Ho MK; Shaw PS; Stone BA; Sands H; Moore GP
Cancer Res; 1987 Jul; 47(13):3577-83. PubMed ID: 3555775
[TBL] [Abstract][Full Text] [Related]
4. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
[TBL] [Abstract][Full Text] [Related]
5. In vivo tumor localization using tumor-specific monkey xenoantibody, alloantibody, and murine monoclonal xenoantibody.
Stuhlmiller GM; Sullivan DC; Vervaert CE; Croker BP; Harris CC; Seigler HF
Ann Surg; 1981 Nov; 194(5):592-601. PubMed ID: 6895297
[TBL] [Abstract][Full Text] [Related]
6. Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma.
Leung SO; Shevitz J; Pellegrini MC; Dion AS; Shih LB; Goldenberg DM; Hansen HJ
Hybridoma; 1994 Dec; 13(6):469-76. PubMed ID: 7737671
[TBL] [Abstract][Full Text] [Related]
7. Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor.
Reinhold U; Liu L; Lüdtke-Handjery HC; Heuser C; Hombach A; Wang X; Tilgen W; Ferrone S; Abken H
J Invest Dermatol; 1999 May; 112(5):744-50. PubMed ID: 10233766
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
Saxton RE; Mann BD; Morton DL; Burk MW
Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
[TBL] [Abstract][Full Text] [Related]
9. Cloning of cDNAs encoding the variable domains of antibody BrE-3 and construction of a chimeric antibody.
Couto JR; Blank EW; Peterson JA; Ceriani RL
Hybridoma; 1993 Feb; 12(1):15-23. PubMed ID: 8454302
[TBL] [Abstract][Full Text] [Related]
10. Tissue specificity of anti melanoma monoclonal antibodies analyzed on cell lines.
Johnson JP; Riethmüller G
Hybridoma; 1982; 1(4):381-5. PubMed ID: 6208134
[TBL] [Abstract][Full Text] [Related]
11. Idiotypic cascade in the human high molecular weight melanoma-associated antigen system: fine specificity and idiotypic profile of anti-anti-idiotypic monoclonal antibodies.
Yang H; Chen ZJ; Kageshita T; Yamada M; Ferrone S
Eur J Immunol; 1993 Jul; 23(7):1671-7. PubMed ID: 7686858
[TBL] [Abstract][Full Text] [Related]
12. Analysis of hybridoma-exchange antibodies.
Lloyd KO; Albino A; Houghton A
Hybridoma; 1982; 1(4):461-3. PubMed ID: 6208140
[No Abstract] [Full Text] [Related]
13. Multiple assay characterization of murine monoclonal antimelanoma antibodies.
Stuhlmiller GM; Borowitz MJ; Croker BP; Seigler HF
Hybridoma; 1982; 1(4):447-60. PubMed ID: 6208139
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
[TBL] [Abstract][Full Text] [Related]
15. Analysis of anti-tumor antibodies in mice and rabbits induced by monoclonal anti-idiotope antibodies.
Chattopadhyay P; Starkey J; Raychaudhuri S
J Immunol; 1991 Sep; 147(6):2055-62. PubMed ID: 1890311
[TBL] [Abstract][Full Text] [Related]
16. Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.
Chen ZJ; Yang H; Liu CC; Hirai S; Ferrone S
Cancer Res; 1993 Jan; 53(1):112-9. PubMed ID: 8416734
[TBL] [Abstract][Full Text] [Related]
17. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.
Couto JR; Blank EW; Peterson JA; Ceriani RL
Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human-mouse chimeric monoclonal antibody specific for human adenocarcinoma associated antigen.
Nakashima M; Nishimura Y; Watanabe T
Hybridoma; 1991 Feb; 10(1):1-9. PubMed ID: 2032728
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1).
Hutzell P; Kashmiri S; Colcher D; Primus FJ; Hand PH; Roselli M; Finch M; Yarranton G; Bodmer M; Whittle N
Cancer Res; 1991 Jan; 51(1):181-9. PubMed ID: 1988082
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo properties of human/mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen.
Saga T; Endo K; Koizumi M; Kawamura Y; Watanabe Y; Konishi J; Ueda R; Nishimura Y; Yokoyama M; Watanabe T
J Nucl Med; 1990 Jun; 31(6):1077-83. PubMed ID: 2348236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
